Vannin Healthcare offers several effective COVID-19 tests:
SGTi-flex COVID-19 IgM/IgG (25 tests per kit)
STANDARD Q COVID-19 IgM/IgG Duo Test (40 tests per kit)
Anti-SARS-CoV-2 Rapid Test (50 tests per kit)
General Features
Can detect and differentiate between IgM and IgG antibodies
Convenient: no additional equipment necessary
Extremely fast: results in 10-15 minutes
Point-of-care testing
Allow rapid decision-making in high-stakes situations
Why our tests
Certified: CE-IVD marked, FDA-cleared, ISO 13485, Korea GMP-certified
Reliable: high clinical specificity and selectivity
Easy to interpret
Can detect antibodies even in asymptomatic patients
Vannin Healthcare Global offers various diagnostic and serology tests for identifying the presence of Severe Acute Respiratory Syndrome Coronavirus2 (SARS-CoV-2). SARS-CoV-2 is the virus that causes COVID-19 which means that its presence could indicate that a person has been infected.
There are two types of tests currently used to determine the presence of the virus:
To find out whether antibodies are present in an obtained sample (whole blood, plasma, or serum), serology tests are used. The presence of antibodies could indicate a past infection. And depending on the type of the immunoglobulins present, it could also determine the approximate time when the infection occurred.
After fighting a coronavirus, our bodies are likely to produce two classes of antibodies: IgM and IgG. In the case of SARS-CoV-2, both IgM and IgG are most likely to occur simultaneously within two to three weeks after a person's been infected. For a firmer diagnosis, Vannin Healthcare Global offers serology tests that check for both IgM and IgG antibodies.
Can detect and differentiate between IgM and IgG antibodies
Differentiating between the antibodies is crucial when it comes to providing proper medical advice to your patients. The appearance of IgM antibodies is the initial response of the organism fighting to suppress the virus. These antibodies could indicate that the patient is still infectious, and advising patients to self-isolate is the appropriate course of action. IgG antibodies can be detected in the blood sample usually within7-10 days after the onset of infection. If a patient has IgG antibodies, and no IgM antibodies, they have developed a temporary immunity to COVID-19.
No additional equipment necessary
The test design makes it a perfect choice for remote areas without access to fully-equipped laboratories. Simply obtain a blood sample from a patient, and add 10�µl into the appropriate place on the testing cassette along with three drops (90µl) of the buffer. The results will appear in 10-15 minutes.
1. Generic Name: Novel Coronavirus COVID-19 IgG Antigen Test Kit
2. Brand Name: NIL
3. Notified Category: Other than above substances intended for qualitative determination of COVID-19 infection
4. Class of Medical Device: Class D
5. Shelf life :15 months
6. Sterile/Non-Sterile: Non-Sterilized
7. Contains Drugs: No
8. Medical Device Grouping Category: IVD-Kit
9. Grouping Description: Intended for qualitative determination of COVID-19 infection
10. Intended Use: The Novel Coronavirus COVID-19 IgG Kit is intended for the qualitative detection of human anti-COVID- 19 IgG antibody in human serum/plasma. Any reactive specimen with the Novel Coronavirus COVID-19 IgG Kit must be confirmed with alternative testing method(s).
11. Product Description: Assay controls and 1:10 diluted human serum samples are added to the microtiter wells of a microplate that was coated with COVID-19 recombinant full length recombinant protein. After the first incubation period, the unbound protein matrix is removed with a subsequent washing step. A horseradish peroxidase (HRP) labeled polyclonal goat anti-human IgG tracer antibody is added to each well. After an incubation period, an immunocomplex of "COVID-19 recombinant antigen-human anti-COVID-19 IgG antibody - HRP labeled anti human IgG tracer antibody" is formed if there is specific Coronavirus IgG antibody present in the tested specimen. The unbound tracer antibody is removed by the subsequent washing step. HRP-Labeled tracer antibody bound to the well is then incubated with a substrate solution in a timed reaction and then measured in a spectrophotometric microplate reader. The enzymatic activity of the tracer antibody bound to the anti-COVID-19 IgG on the wall of the microtiter well is proportional to the amount of the anti-COVID-19 IgG antibody level in the tested specimen.
SALIENT FEATURES:
â?¢ Recombinant COVID-19 Spike subunit Protein coated on Microwell Plate
â?¢ HRP Conjugated Polyvalent Anti-Human IgG
â?¢ Assay Time: 80 mins (30mins+30 Mins+20mins)
â?¢ Strip Format Microwell Plate
â?¢ Ready to use Substrate and Controls
â?¢ Only 20 pL of human serum is required for measurement in duplicate.
â?¢ Works on any open ELISA system
â?¢ Assay procedure is easy to automate
OUR TEST:
â?¢ Principle: Indirect ELISA
â?¢ The normal healthy patients with samples collected prior to the COVID-19 outbreak [December 3, 2019] (n = 150) and RT-PCR confirmed positive patients in after the second week of the onset of the disease (n = 32). The Positive sample evaluation was done at external Approved Lab. The results are as follows:
â?¢ Diagnostic sensitivity is 100% (>98%)
â?¢ Diagnostic specificity is 98.67% (>97%)
â?¢ PPV: 94.12�°/0
â?¢ NPV: 100%
Please contact us for more information and product details.
Novel Coronavirus (2019-nCoV) Real-time RT-PCR Kit is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from the 2019-nCoV in oropharyngeal swabs and bronchoalveolar lavage fluid collected from individuals suspected of COVID-19 by their healthcare provider.
INVBIO Covid Antigen Ag saliva rapid test card
Sensitivity: 97.1%
Specificity: 99%
Agreement: 99.57%
10 miuntes to get the result. MOQ for each: 500 tests, 25 tests/box,
Novel Coronavirus (2019-nCoV) Real-time RT-PCR Kit is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from the 2019-nCoV in oropharyngeal swabs and bronchoalveolar lavage fluid collected form individuals suspected of COVID-19 by their healthcare provider.
About SARS-CoV-2
Specific antibodies will be produced within days to weeks as the immune system makes immune defense against the SARS-CoV-2 infection. Total antibody detection is an aid in the diagnosis of patients with suspected SARS-CoV-2 infection in conjunction with clinical symptoms and result of other diagnostic methods. The test result should not be used as the sole basis for diagnosis and exclusion of SARS-CoV-2 infection. Total antibody may not be detected in the first few days of infection.
SARS-CoV-2 neutralizing antibody is a protective soluble protein secreted by adaptive immunizing cells after inoculation with SARS-CoV-2 vaccine or infection with SARS-CoV-2. These antibodies can specific bind with virus RNA binding domain (RBD) to block the binding of RBD with angiotensin-converting enzyme 2 (ACE2) on human cells surface, thus prevent the virus or its genetic material into the human cell and virus infection.
Benifits of the Kit
1) Room Temperature Transportation
2) Cost-Effective Shipping
The shipping is at room temperature, with no need of cold chain shipping.
3) Highly Sensitive, Highly Specific
Highly sensitive and highly specific for 2019-nCoV, reliable identification of COVID-19.
4) Environmentally Friendly
The kit needs neither bulky packaging nor cold chain shipping.
Canine Coronavirus Ag Test is a sandwich lateral flow immunochromatographic assay for the qualitative detection of Canine Coronavirus (CCV Ag) in dog's feces or vomit.
Assay Time: 5 -10 min.
Sample: Feces or vomit.
Canine Coronavirus Ag Test is based on sandwich lateral flow immunochromatographic assay. The test device has a testing window. The testing window has an invisible T (test) zone and C (control) zone. When sample is applied into the sample hole on the device, the liquid will laterally flow on the surface of the test strip. If there is enough Coronavirus antigen in the sample, a visible T band will appear. The C band should always appear after a sample is applied, indicating a valid result. By this means, the device can accurately indicate the presence of Canine Coronavirus antigen in the sample.
Feline Coronavirus Ab Test is a sandwich lateral flow immunochromatographic assay for the qualitative detection of Feline Coronavirus antibody (FCoV Ab) in cat's blood.
Assay Time: 5-10 mins
Sample: serum, plasma or blood
Feline Coronavirus Ab Test is based on sandwich lateral flow immunochromatographic assay. The test device has a testing window. The testing window has an invisible T (test) zone and C (control) zone. When sample is applied into the sample hole on the device, the liquid will laterally flow on the surface of the test strip. If there is enough FCoV antibody in the sample, a visible T band will appear. The C band should always appear after a sample is applied, indicating a valid result. By this means, the device can accurately indicate the presence of Feline Coronavirus antibody in the sample.
